Pharmaceuticals
EU lifts ban on Ranbaxy’s Toansa-made drugs
06 Jun 2014
European regulators on Thursday lifted the EU ban on drugs manufactured at Ranbaxy Laboratories' Toansa plant, saying they do not pose a risk to public health
US FDA gives `fast-track’ status for AstraZeneca’s novel antibiotic for treatment of gonorrhea
04 Jun 2014
FDA hits Wockhardt again; this time over Illinois plant
04 Jun 2014
Wockhardt again faces strictures from the US FDA – this time over its facility in Chicago in Illinois
Stryker denies Smith & Nephew bid
29 May 2014
Valeant raises Allergan bid to $49.44 bn: analysts say new offer still too low
29 May 2014
A successful deal with Allergan would more than double the size of Valeant and make it one of the largest specialty pharmaceutical companies in the world
British watchdog launches criminal probe into GSK over bribery
28 May 2014
The UK Serious Fraud Office (SFO) has launched a criminal investigation into drug giant GlaxoSmithKline (GSK) over alleged bribery in China and in other countries
.webp)
.webp)
